$3.06 Billion is the total value of E Fund Management Co., Ltd.'s 325 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR Gold MiniShares Trustetp | $4,955,000 | – | 128,809 | +100.0% | 0.16% | – | |
| AZN | New | AstraZeneca PLCadr | $360,000 | – | 5,427 | +100.0% | 0.01% | – |
| ODFL | New | Old Dominion Freight Line Inc | $381,000 | – | 1,274 | +100.0% | 0.01% | – |
| ARCT | New | Arcturus Therapeutics Holdings | $321,000 | – | 11,910 | +100.0% | 0.01% | – |
| CDNA | New | CareDx Inc | $322,000 | – | 8,715 | +100.0% | 0.01% | – |
| EDIT | New | Editas Medicine Inc | $339,000 | – | 17,812 | +100.0% | 0.01% | – |
| GBT | New | Global Blood Therapeutics Inc | $334,000 | – | 9,646 | +100.0% | 0.01% | – |
| IOVA | New | Iovance Biotherapeutics Inc | $339,000 | – | 20,353 | +100.0% | 0.01% | – |
| KRTX | New | Karuna Therapeutics Inc | $331,000 | – | 2,607 | +100.0% | 0.01% | – |
| VCYT | New | Veracyte Inc | $311,000 | – | 11,276 | +100.0% | 0.01% | – |
| EBS | New | Emergent BioSolutions Inc | $302,000 | – | 7,354 | +100.0% | 0.01% | – |
| APLS | New | Apellis Pharmaceuticals Inc | $315,000 | – | 6,196 | +100.0% | 0.01% | – |
| NTLA | New | Intellia Therapeutics Inc | $318,000 | – | 4,377 | +100.0% | 0.01% | – |
| ARWR | New | Arrowhead Pharmaceuticals Inc | $295,000 | – | 6,421 | +100.0% | 0.01% | – |
| VIR | New | Vir Biotechnology Inc | $316,000 | – | 12,283 | +100.0% | 0.01% | – |
| BPMC | New | Blueprint Medicines Corp | $300,000 | – | 4,698 | +100.0% | 0.01% | – |
| RARE | New | Ultragenyx Pharmaceutical Inc | $298,000 | – | 4,101 | +100.0% | 0.01% | – |
| TWST | New | Twist Bioscience Corp | $303,000 | – | 6,126 | +100.0% | 0.01% | – |
| EXAS | New | Exact Sciences Corp | $299,000 | – | 4,275 | +100.0% | 0.01% | – |
| IONS | New | Ionis Pharmaceuticals Inc | $309,000 | – | 8,334 | +100.0% | 0.01% | – |
| BBIO | New | Bridgebio Pharma Inc | $317,000 | – | 31,264 | +100.0% | 0.01% | – |
| PTCT | New | PTC Therapeutics Inc | $292,000 | – | 7,830 | +100.0% | 0.01% | – |
| NVAX | New | Novavax Inc | $271,000 | – | 3,676 | +100.0% | 0.01% | – |
| BMRN | New | BioMarin Pharmaceutical Inc | $272,000 | – | 3,531 | +100.0% | 0.01% | – |
| UTHR | New | United Therapeutics Corp | $278,000 | – | 1,551 | +100.0% | 0.01% | – |
| DNLI | New | Denali Therapeutics Inc | $284,000 | – | 8,827 | +100.0% | 0.01% | – |
| SAGE | New | Sage Therapeutics Inc | $286,000 | – | 8,634 | +100.0% | 0.01% | – |
| SRPT | New | Sarepta Therapeutics Inc | $269,000 | – | 3,446 | +100.0% | 0.01% | – |
| ACAD | New | ACADIA Pharmaceuticals Inc | $280,000 | – | 11,573 | +100.0% | 0.01% | – |
| CLDX | New | Celldex Therapeutics Inc | $267,000 | – | 7,838 | +100.0% | 0.01% | – |
| CCXI | New | ChemoCentryx Inc | $284,000 | – | 11,309 | +100.0% | 0.01% | – |
| PRTA | New | Prothena Corp PLC | $263,000 | – | 7,202 | +100.0% | 0.01% | – |
| AGIO | New | Agios Pharmaceuticals Inc | $260,000 | – | 8,923 | +100.0% | 0.01% | – |
| INSM | New | Insmed Inc | $285,000 | – | 12,116 | +100.0% | 0.01% | – |
| HZNP | New | Horizon Therapeutics Plc | $280,000 | – | 2,663 | +100.0% | 0.01% | – |
| ALKS | New | Alkermes PLC | $289,000 | – | 11,003 | +100.0% | 0.01% | – |
| LGND | New | Ligand Pharmaceuticals Inc | $270,000 | – | 2,399 | +100.0% | 0.01% | – |
| MRTX | New | Mirati Therapeutics Inc | $273,000 | – | 3,321 | +100.0% | 0.01% | – |
| ZNTL | New | Zentalis Pharmaceuticals Inc | $280,000 | – | 6,079 | +100.0% | 0.01% | – |
| NTRA | New | Natera Inc | $280,000 | – | 6,882 | +100.0% | 0.01% | – |
| ALNY | New | Alnylam Pharmaceuticals Inc | $283,000 | – | 1,732 | +100.0% | 0.01% | – |
| NBIX | New | Neurocrine Biosciences Inc | $282,000 | – | 3,005 | +100.0% | 0.01% | – |
| PTGX | New | Protagonist Therapeutics Inc | $247,000 | – | 10,440 | +100.0% | 0.01% | – |
| RLAY | New | Relay Therapeutics Inc | $250,000 | – | 8,365 | +100.0% | 0.01% | – |
| SWTX | New | SpringWorks Therapeutics Inc | $257,000 | – | 4,557 | +100.0% | 0.01% | – |
| BEAM | New | Beam Therapeutics Inc | $252,000 | – | 4,404 | +100.0% | 0.01% | – |
| VCEL | New | Vericel Corp | $240,000 | – | 6,269 | +100.0% | 0.01% | – |
| RCUS | New | Arcus Biosciences Inc | $256,000 | – | 8,105 | +100.0% | 0.01% | – |
| ALLO | New | Allogene Therapeutics Inc | $258,000 | – | 28,315 | +100.0% | 0.01% | – |
| LMT | New | Lockheed Martin Corp | $211,000 | – | 479 | +100.0% | 0.01% | – |
| TVTX | New | Travere Therapeutics Inc | $205,000 | – | 7,951 | +100.0% | 0.01% | – |
| FLT | New | FleetCor Technologies Inc | $206,000 | – | 829 | +100.0% | 0.01% | – |
| KRYS | New | Krystal Biotech Inc | $200,000 | – | 3,011 | +100.0% | 0.01% | – |
| AVXL | New | Anavex Life Sciences Corp | $227,000 | – | 18,467 | +100.0% | 0.01% | – |
| SPLK | New | Splunk Inc | $226,000 | – | 1,520 | +100.0% | 0.01% | – |
| SANA | New | Sana Biotechnology Inc | $201,000 | – | 24,328 | +100.0% | 0.01% | – |
| MDGL | New | Madrigal Pharmaceuticals Inc | $228,000 | – | 2,322 | +100.0% | 0.01% | – |
| ENTA | New | Enanta Pharmaceuticals Inc | $206,000 | – | 2,890 | +100.0% | 0.01% | – |
| CDMO | New | Avid Bioservices Inc | $221,000 | – | 10,835 | +100.0% | 0.01% | – |
| VERV | New | Verve Therapeutics Inc | $212,000 | – | 9,282 | +100.0% | 0.01% | – |
| TDY | New | Teledyne Technologies Inc | $225,000 | – | 477 | +100.0% | 0.01% | – |
| New | Constellation Energy Corp | $209,000 | – | 3,722 | +100.0% | 0.01% | – | |
| New | 2seventy bio Inc | $188,000 | – | 11,035 | +100.0% | 0.01% | – | |
| ICPT | New | Intercept Pharmaceuticals Inc | $186,000 | – | 11,431 | +100.0% | 0.01% | – |
| CHRS | New | Coherus Biosciences Inc | $174,000 | – | 13,486 | +100.0% | 0.01% | – |
| MYOV | New | Myovant Sciences Ltd | $181,000 | – | 13,601 | +100.0% | 0.01% | – |
| ATRA | New | Atara Biotherapeutics Inc | $180,000 | – | 19,420 | +100.0% | 0.01% | – |
| New | DermTech Inc | $164,000 | – | 11,153 | +100.0% | 0.01% | – | |
| FGEN | New | FibroGen Inc | $167,000 | – | 13,904 | +100.0% | 0.01% | – |
| ALEC | New | Alector Inc | $163,000 | – | 11,434 | +100.0% | 0.01% | – |
| MGNX | New | MacroGenics Inc | $92,000 | – | 10,417 | +100.0% | 0.00% | – |
| CPRX | New | Catalyst Pharmaceuticals Inc | $96,000 | – | 11,614 | +100.0% | 0.00% | – |
| MDXG | New | MiMedx Group Inc | $50,000 | – | 10,673 | +100.0% | 0.00% | – |
| CMRX | New | Chimerix Inc | $59,000 | – | 12,868 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PINDUODUO INC-ADR | 10 | Q3 2023 | 34.7% |
| KE HOLDINGS INC-ADR | 10 | Q3 2023 | 7.5% |
| MICROSOFT CORP | 10 | Q3 2023 | 5.0% |
| STAAR SURGICAL CO | 10 | Q3 2023 | 4.8% |
| APPLE INC | 10 | Q3 2023 | 3.3% |
| Tencent Music Entertainment Gr | 10 | Q3 2023 | 6.2% |
| VIPSHOP HOLDINGS LTD - ADR | 10 | Q3 2023 | 3.0% |
| TAL EDUCATION GROUP- ADR | 10 | Q3 2023 | 4.9% |
| Advanced Micro Devices Inc | 10 | Q3 2023 | 2.9% |
| ASML HOLDING NV-NY REG SHS | 10 | Q3 2023 | 2.4% |
View E Fund Management Co., Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View E Fund Management Co., Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.